Fire needling therapy in post-stroke complex regional pain syndrome of the upper limb: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068841

Enrollment

Unknown

Registered

2023-03-01

Start date

2023-03-01

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke complex regional pain syndrome of the upper limb

Interventions

He's fire needle group:Fire needle

Filiform needle group:Filiform needle

Eligibility

Sex/Gender

All

Age

45 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 40-75 years, male or female 2. Diagnosed with stroke based on National Institute for Health and Clinical Excellence (NICE) Guidelines 2019 Edition (within 2 weeks to 3 months after the onset of stroke) 3. Total?or?partial?anterior?circulation infarction confirmed by CT or MRI 4. Diagnosed with CRSP of the upper limb according to the Budapest criteria, and an average pain intensity>= 4 on an 11-point numerical rating scale (NRS) in the last week 5. Muscle strength of affected upper limb <= 3 6. Fugl-Meyer Assessment <= 54 7. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Having severe posterior circulation infarction, thalamic infarction, progressive stroke, cerebral embolism, brain tumor 2.Having hemorrhagic disease, liver and kidney disease, metabolic disease, hematopoietic system disease, infectious disease or other severe acute or chronic organic diseases that belong to the contraindication of fire needling therapy 3. Had two or more stroke 4. Shoulder and hand dysfunction existed before the stroke or caused by other reasons (upper limb fracture, periarthritis of shoulder, peripheral nerve injury, etc.) 5. Having sensory abnormalities, especially having abnormal pain threshold 6. Having undergone acupuncture therapy within 3 months 7. Having mental disorders or severe cognitive disorders 8. Pregnant or breastfeeding women 9. Having participated in other clinical trials within 3 months 10. Unable to cooperate or unwilling to comply with all study requirements 11. Cardiac pacemaker, metal allergy or fire needle phobia

Design outcomes

Primary

Measure	Time frame
The effective response rate;	—

Secondary

Measure	Time frame
visual analogue scale;Fugl-Meyer Assessment;Activity of Daily Living;Pressure Pain Threshold;	—

Countries

China

Contacts

Public ContactZhang Fan

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

wawndzh@126.com+86 135 8152 1553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026